CARDIOVASCULAR CONSIDERATIONS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION (HB 2024). This item is unavailable.
Language: English
Published by SPRINGER NP, 2024
- Hardcover
- Used
Seller: UK BOOKS STORE, London, London, United KingdomUK BOOKS STORE
5-star seller
AbeBooks seller since March 11, 2024
International Edition
Unavailable
Hardcover
Condition: Used
£ 183.56
Item description from seller
Brand New! Fast Delivery This is an International Edition and ship within 24-48 hours. Deliver by FedEx and Dhl, & Aramex, UPS, & USPS and we do accept APO and PO BOX Addresses. Order can be delivered worldwide within 6-10 days and we do have flat rate for up to 2LB. Extra shipping charges will be requested if the Book weight is more than 5 LB. This Item May be shipped from India, United states & United Kingdom. Depending on your location and availability.
Seller Inventory # CBS 9783031536588
- Title
- CARDIOVASCULAR CONSIDERATIONS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION (HB 2024)
- Author
- ALIZADEHASL A.
- Publisher
- SPRINGER NP
- Publication year
- 2024
- Condition
- New Books
- Binding
- Hardcover
- Language
- English
- ISBN 10
- 3031536584
- ISBN 13
- 9783031536588
- Edition
- International Edition
This book discusses the epidemiology and the known cardiotoxic effects of chemoradiation agents in addition to newer therapies in hematopoietic stem cell transplantation (HSCT). Recent expert consensus statements from cardiology and hematology/oncology societies are reviewed in regard to risk stratification of the patient based on the type of treatments they are undergoing. Finally, gaps in knowledge are identified with proposed avenues of research that allow for more accurate risk assessment, prediction and potential treatment of the HSCT patient in attenuating the risk of developing cardiovascular comorbidities.
"Synopsis" may belong to another edition of this title.
About the Author
Dr. Azin Alizadehasl, a cardio-oncologist and echocardiologist, stands as the head and founder of the first cardio-oncology ward and research center at Rajaei Heart Institute in Iran. Currently serving as the assistant professor at Rajaei Heart Institute, she embarked on her medical degree as the first rank student and expanding her knowledge through diverse courses in the USA and Canada, Dr. Alizadehasl has achieved noteworthy distinctions, including the Fellowship of the American Society of Echocardiography (FASE) and the Fellowship of the American College of Cardiology (FACC).
Professor Ardeshir Ghavamzadeh is widely recognized as the pioneer of hemato-oncology in Iran. He holds the distinction of being the first individual to perform a Bone Marrow Transplant (BMT) in the country. In recognition of his exceptional contributions, he was honored with the prestigious CIBMTR Distinguished Service Award in 2012.
Dr. Amirhossein Emami is an assistant professor of hemato-oncology at Tehran University of Medical Sciences, currently he is the head of hemato-oncology and stem cell transplantation ward of Imam Khomeini Hospital of Tehran. He has previously held the position of head of Tehran Medical School. He was bestowed with the prestigious "Medical Education Award" in 2011. His primary area of expertise revolves around advancing oncology care by fostering the growth of multi-disciplinary teams, with a specific focus on colorectal malignancies
Dr. Ghasem Janbabaei is a hemato-oncologist at Tehran University of Medical Science. He has achieved the 3rd rank in the board certification of Internal Medicine in Iran. He has previously served as the head of the Deputy of Medical Affairs at the Ministry of Health in Iran and has authored approximately 200 articles in the field of oncology.
Dr. Davood Khoda-Amorzideh is a cardiologist and the first graduate of the cardio-oncology fellowship in Iran. He has published numerous books in the field of cardiology, including translations of reference books in Persian for medical doctors. Additionally, he has authored several articles in the field of cardio-oncology. Currently, he is actively involved in the treatment of cardiac complications in cancer patients in Tehran.
"About the title" may belong to another edition of this title.
Search results for CARDIOVASCULAR CONSIDERATIONS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION (HB 2024)
There are 3 more copies of this bookView all results